111 related articles for article (PubMed ID: 1575724)
21. Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors.
Desiderio C; D'Angelo L; Rossetti DV; Iavarone F; Giardina B; Castagnola M; Massimi L; Tamburrini G; Di Rocco C
Proteomics; 2012 Jul; 12(13):2158-66. PubMed ID: 22623401
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of a bradykinin-potentiating peptide from a bovine peptic hemoglobin hydrolysate.
Piot JM; Zhao Q; Guillochon D; Ricart G; Thomas D
FEBS Lett; 1992 Mar; 299(1):75-9. PubMed ID: 1544478
[TBL] [Abstract][Full Text] [Related]
23. The binding of xanthochromic compounds in the cerebrospinal fluid. Preliminary report.
Kjellin KG
J Neurol Sci; 1969; 9(3):597-601. PubMed ID: 5367046
[No Abstract] [Full Text] [Related]
24. Color Doppler flow imaging of CSF flow in infants with intracranial hemorrhage.
Tatsuno M; Hasegawa M; Iwasaki J; Saito Y
Brain Dev; 1993; 15(5):333-9. PubMed ID: 7904132
[TBL] [Abstract][Full Text] [Related]
25. Hemorphin and hemorphin-like peptides isolated from dog pancreas and sheep brain are able to potentiate bradykinin activity in vivo.
Ianzer D; Konno K; Xavier CH; Stöcklin R; Santos RA; de Camargo AC; Pimenta DC
Peptides; 2006 Nov; 27(11):2957-66. PubMed ID: 16904236
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic value of determining hemoglobin in cerebrospinal fluid in acute cerebral circulatory disorders].
Guner MM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(9):1300-2. PubMed ID: 919951
[TBL] [Abstract][Full Text] [Related]
27. In vivo processing of LVV-hemorphin-7 in rat brain and blood utilizing microdialysis combined with electrospray mass spectrometry.
Nydahl KS; Pierson J; Nyberg F; Caprioli RM; Andrén PE
Rapid Commun Mass Spectrom; 2003; 17(8):838-44. PubMed ID: 12672139
[TBL] [Abstract][Full Text] [Related]
28. In vitro metabolism of LVV-hemorphin-7 in human plasma studied by reversed-phase high-performance liquid chromatography and micro-electrospray mass spectrometry.
Sanderson K; Andrén PE; Caprioli RM; Nyberg F
J Chromatogr A; 1996 Aug; 743(1):207-12. PubMed ID: 8817883
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of appearance of hemorphins from bovine hemoglobin peptic hydrolysates by a direct coupling of reversed-phase high-performance liquid chromatography and electrospray ionization mass spectrometry.
Froidevaux R; Lignot B; Nedjar-Arroume N; Guillochon D; Coddeville B; Ricart G
J Chromatogr A; 2000 Mar; 873(2):185-94. PubMed ID: 10757296
[TBL] [Abstract][Full Text] [Related]
30. [Increased intracranial pressure following hemorrhage into CSF space (authors transl)].
Yamamoto S; Hayashi M; Fujii H
No Shinkei Geka; 1976 Dec; 4(12):1125-36. PubMed ID: 794751
[No Abstract] [Full Text] [Related]
31. Experimental determination of time of intracranial hemorrhage by spectrophotometric analysis of cerebrospinal fluid.
Marlet JM; Barreto Fonseca Jde P
J Forensic Sci; 1982 Oct; 27(4):880-8. PubMed ID: 7175468
[TBL] [Abstract][Full Text] [Related]
32. Quantification of hemorphins in Alzheimer's disease brains.
Poljak A; McLean CA; Sachdev P; Brodaty H; Smythe GA
J Neurosci Res; 2004 Mar; 75(5):704-14. PubMed ID: 14991846
[TBL] [Abstract][Full Text] [Related]
33. Changes in the level of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid after subarachnoid hemorrhage.
Nagata K; Seyama Y; Shimizu T
Neurol Med Chir (Tokyo); 1995 May; 35(5):294-7. PubMed ID: 7623950
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of intraerythrocytic proteasome retards the generation of hemorphins.
Song CZ; Wang QW; Liu H; Song CC
Peptides; 2012 Jan; 33(1):170-3. PubMed ID: 22154669
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro degradation of the human hemorphin LVV-H7 in mammalian plasma analysed by capillary zone electrophoresis and mass spectrometry.
John H; Schulz S; Forssmann WG
Biopharm Drug Dispos; 2007 Mar; 28(2):73-85. PubMed ID: 17173283
[TBL] [Abstract][Full Text] [Related]
36. Pigment changes in the lumbar fluid as a diagnostic aid in intracranial haemorrhagic lesions.
KRONHOLM V; LINTRUP J
Dan Med Bull; 1961 May; 8():47-9. PubMed ID: 13754503
[No Abstract] [Full Text] [Related]
37. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7.
Dagouassat N; Garreau I; Zhao Q; Sannier F; Piot JM
Neuropeptides; 1996 Feb; 30(1):1-5. PubMed ID: 8868292
[TBL] [Abstract][Full Text] [Related]
38. Molecular insights into the interaction of hemorphin and its targets.
Ali A; Baby B; Soman SS; Vijayan R
Sci Rep; 2019 Oct; 9(1):14747. PubMed ID: 31611567
[TBL] [Abstract][Full Text] [Related]
39. Release of hemorphin-5 from human hemoglobin by pancreatic elastase.
Jinsmaa Y; Yoshikawa M
Biosci Biotechnol Biochem; 2002 May; 66(5):1130-2. PubMed ID: 12092829
[TBL] [Abstract][Full Text] [Related]
40. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.
Miller DL; Papayannopoulos IA; Styles J; Bobin SA; Lin YY; Biemann K; Iqbal K
Arch Biochem Biophys; 1993 Feb; 301(1):41-52. PubMed ID: 8442665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
